Evaluation and Measurement of Potential Genotoxic Impurities in Empagliflozin Active Pharmaceutical Ingredient Using Tandem Liquid Chromatography Mass Spectrometer, Accompanied by an Advanced Greenness Assessment

Documenti analoghi

• Green Tandem Mass Spectrometry Method for Carcinogenic Nitrosamine Impurity Determination in Oral‐Gonadotropin Releasing Hormone Receptor Antagonist Drug
  di: Ramya Chilukuri, et al.
  Pubblicazione: (2026)
• Liquid Chromatography–Mass Spectrometry Method for Determination of N ‐Methyl‐ N ‐Nitrosopyridin‐4‐Amine in a Vonoprazan Fumarate Drug
  di: Ramya Chilukuri, et al.
  Pubblicazione: (2024)
• Development and Validation of Trace Level Quantification of Nine Azido Genotoxic Impurities in Losartan Potassium Active Pharmaceutical Ingredients by Liquid Chromatography‐Tandem Mass Spectrometry
  di: Praveen Kumar Kondaveti, et al.
  Pubblicazione: (2024)
• Novel Potential Genotoxic Impurity Identification and Quantification by Using Quality by Design Approach in Angiotensin II Receptor Blocker
  di: Yerramreddy Srilatha, et al.
  Pubblicazione: (2025)
• Application of Liquid Chromatography Tandem Mass Spectrometry for Trace‐Level Detection of Potential Genotoxic Impurities in Edaravone Bulk and Parenteral Dosage Forms
  di: Venkata Lakshamana Sagar Dantinapalli, et al.
  Pubblicazione: (2025)